0B68 Cristofanilli, Massimo - Thomas Jefferson University - Thomas Jefferson University
mxc156

Massimo Cristofanilli, MD

Contact Dr. Cristofanilli

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines
  2. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
  3. Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy
  4. Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
  5. Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy
  6. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: Preclinical activity in HER2 non-amplified inflammatory breast cancer models
  7. Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer
  8. Circulating giant macrophages as a potential biomarker of solid tumors
  9. Gene expression profiles of inflammatory breast cancer: Correlation with response to neoadjuvant chemotherapy and metastasis-free survival
  10. Circulating tumour cells: Telling the truth about metastasis
  11. Biomarkers and Therapeutic Targets in Inflammatory Breast Cancer (IBC)
  12. Survival of women with inflammatory breast cancer: A large population-based study
  13. Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib
  14. PARP inhibitors for chemoprevention - Letter
  15. A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populations
  16. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
  17. Presence of anaplastic lymphoma kinase in inflammatory breast cancer
  18. The Third International Inflammatory Breast Cancer Conference
  19. Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): A multicenter, double-blind, prospective trial
  20. EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
0